Peptide Therapeutics Market Research Report by Technology (Hybrid Phase, Liquid Phase, and Solid Phase), by API Type (CMO and In-house), by Drug Class, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Peptide Therapeutics Market is expected to grow from USD 24,461.45 Million in 2020 to USD 41,146.68 Million by the end of 2025.
2. The Global Peptide Therapeutics Market is expected to grow from EUR 21,448.26 Million in 2020 to EUR 36,078.19 Million by the end of 2025.
3. The Global Peptide Therapeutics Market is expected to grow from GBP 19,067.55 Million in 2020 to GBP 32,073.59 Million by the end of 2025.
4. The Global Peptide Therapeutics Market is expected to grow from JPY 2,610,657.01 Million in 2020 to JPY 4,391,393.70 Million by the end of 2025.
5. The Global Peptide Therapeutics Market is expected to grow from AUD 35,521.28 Million in 2020 to AUD 59,750.45 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Peptide Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Liquid Phase is projected to witness the highest growth during the forecast period'
Based on Technology, the Peptide Therapeutics Market studied across Hybrid Phase, Liquid Phase, and Solid Phase. The Liquid Phase commanded the largest size in the Peptide Therapeutics Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The CMO is projected to witness the highest growth during the forecast period'
Based on API Type, the Peptide Therapeutics Market studied across CMO and In-house. The In-house commanded the largest size in the Peptide Therapeutics Market in 2020. On the other hand, the CMO is expected to grow at the fastest CAGR during the forecast period.
'The Glucagon & Analogs is projected to witness the highest growth during the forecast period'
Based on Drug Class, the Peptide Therapeutics Market studied across Calcitonins, Glucagon & Analogs, Insulins, Luteinizing Hormone-Releasing Hormone, Somatostatins, and Vasopressin. The Insulins commanded the largest size in the Peptide Therapeutics Market in 2020. On the other hand, the Glucagon & Analogs is expected to grow at the fastest CAGR during the forecast period.
'The Anti-infective is projected to witness the highest growth during the forecast period'
Based on Application, the Peptide Therapeutics Market studied across Anti-infective, Cancer, Cardio Vascular Disease Respiratory, Central Nervous System, Dermatology, Gastrointestinal, Metabolic, and Renal. The Cancer commanded the largest size in the Peptide Therapeutics Market in 2020. On the other hand, the Anti-infective is expected to grow at the fastest CAGR during the forecast period.
'The Pharmaceutical Industries is projected to witness the highest growth during the forecast period'
Based on End User, the Peptide Therapeutics Market studied across Hospitals, Pharmaceutical Industries, and Research Laboratories. The Pharmaceutical Industries commanded the largest size in the Peptide Therapeutics Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Peptide Therapeutics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Peptide Therapeutics Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Peptide Therapeutics Market including AmbioPharm Inc., Amgen Inc., AstraZeneca PLC, Bachem Holding AG, Bristol-Myers Squibb Company, CordenPharma International, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Hemmo Pharmaceuticals Pvt Ltd., Ipsen S.A., Merck & Co., Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., PolyPeptide Group, Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Zealand Pharma A/S.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Peptide Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Peptide Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Peptide Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Peptide Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Peptide Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Peptide Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Peptide Therapeutics Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Peptide Therapeutics Market is expected to grow from USD 24,461.45 Million in 2020 to USD 41,146.68 Million by the end of 2025.
2. The Global Peptide Therapeutics Market is expected to grow from EUR 21,448.26 Million in 2020 to EUR 36,078.19 Million by the end of 2025.
3. The Global Peptide Therapeutics Market is expected to grow from GBP 19,067.55 Million in 2020 to GBP 32,073.59 Million by the end of 2025.
4. The Global Peptide Therapeutics Market is expected to grow from JPY 2,610,657.01 Million in 2020 to JPY 4,391,393.70 Million by the end of 2025.
5. The Global Peptide Therapeutics Market is expected to grow from AUD 35,521.28 Million in 2020 to AUD 59,750.45 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Peptide Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Liquid Phase is projected to witness the highest growth during the forecast period'
Based on Technology, the Peptide Therapeutics Market studied across Hybrid Phase, Liquid Phase, and Solid Phase. The Liquid Phase commanded the largest size in the Peptide Therapeutics Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The CMO is projected to witness the highest growth during the forecast period'
Based on API Type, the Peptide Therapeutics Market studied across CMO and In-house. The In-house commanded the largest size in the Peptide Therapeutics Market in 2020. On the other hand, the CMO is expected to grow at the fastest CAGR during the forecast period.
'The Glucagon & Analogs is projected to witness the highest growth during the forecast period'
Based on Drug Class, the Peptide Therapeutics Market studied across Calcitonins, Glucagon & Analogs, Insulins, Luteinizing Hormone-Releasing Hormone, Somatostatins, and Vasopressin. The Insulins commanded the largest size in the Peptide Therapeutics Market in 2020. On the other hand, the Glucagon & Analogs is expected to grow at the fastest CAGR during the forecast period.
'The Anti-infective is projected to witness the highest growth during the forecast period'
Based on Application, the Peptide Therapeutics Market studied across Anti-infective, Cancer, Cardio Vascular Disease Respiratory, Central Nervous System, Dermatology, Gastrointestinal, Metabolic, and Renal. The Cancer commanded the largest size in the Peptide Therapeutics Market in 2020. On the other hand, the Anti-infective is expected to grow at the fastest CAGR during the forecast period.
'The Pharmaceutical Industries is projected to witness the highest growth during the forecast period'
Based on End User, the Peptide Therapeutics Market studied across Hospitals, Pharmaceutical Industries, and Research Laboratories. The Pharmaceutical Industries commanded the largest size in the Peptide Therapeutics Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Peptide Therapeutics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Peptide Therapeutics Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Peptide Therapeutics Market including AmbioPharm Inc., Amgen Inc., AstraZeneca PLC, Bachem Holding AG, Bristol-Myers Squibb Company, CordenPharma International, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Hemmo Pharmaceuticals Pvt Ltd., Ipsen S.A., Merck & Co., Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., PolyPeptide Group, Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Zealand Pharma A/S.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Peptide Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Peptide Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Peptide Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Peptide Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Peptide Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Peptide Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the Global Peptide Therapeutics Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. API Type Outlook
3.4. Drug Class Outlook
3.5. Technology Outlook
3.6. Application Outlook
3.7. End User Outlook
3.8. Geography Outlook
3.9. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cancer, cardiovascular disorders (CVDs) and metabolic disorder
5.1.1.2. Technology advancement and R & D investment in new peptides
5.1.2. Restraints
5.1.2.1. Poor chemical and physical stability and a short circulating plasma half-life of naturally occurring peptides
5.1.3. Opportunities
5.1.3.1. Presence of strong product pipeline portfolio
5.1.3.2. Adoption of new platforms that develop next-generation protein or peptide therapeutics
5.1.4. Challenges
5.1.4.1. Presence of stringent safety regulations
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Hybrid Phase
6.3. Liquid Phase
6.4. Solid Phase
7. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY API TYPE
7.1. Introduction
7.2. CMO
7.3. In-house
8. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY DRUG CLASS
8.1. Introduction
8.2. Calcitonins
8.3. Glucagon & Analogs
8.4. Insulins
8.5. Luteinizing Hormone-Releasing Hormone
8.6. Somatostatins
8.7. Vasopressin
9. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY APPLICATION
9.1. Introduction
9.2. Anti-infective
9.3. Cancer
9.4. Cardio Vascular Disease Respiratory
9.5. Central Nervous System
9.6. Dermatology
9.7. Gastrointestinal
9.8. Metabolic
9.9. Renal
10. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY END USER
10.1. Introduction
10.2. Hospitals
10.3. Pharmaceutical Industries
10.4. Research Laboratories
11. AMERICAS PEPTIDE THERAPEUTICS MARKET
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand
13. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. COMPETITIVE LANDSCAPE
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. COMPANY USABILITY PROFILES
15.1. AmbioPharm Inc.
15.2. Amgen Inc.
15.3. AstraZeneca PLC
15.4. Bachem Holding AG
15.5. Bristol-Myers Squibb Company
15.6. CordenPharma International
15.7. Eli Lilly and Company
15.8. F. Hoffmann-La Roche AG
15.9. GlaxoSmithKline PLC
15.10. Hemmo Pharmaceuticals Pvt Ltd.
15.11. Ipsen S.A.
15.12. Merck & Co., Inc.
15.13. Novartis International AG
15.14. Novo Nordisk A/S
15.15. Pfizer Inc.
15.16. PolyPeptide Group
15.17. Sanofi S.A.
15.18. Takeda Pharmaceutical Company Limited
15.19. Teva Pharmaceutical Industries Ltd.
15.20. Zealand Pharma A/S
16. APPENDIX
16.1. Discussion Guide
16.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. API Type Outlook
3.4. Drug Class Outlook
3.5. Technology Outlook
3.6. Application Outlook
3.7. End User Outlook
3.8. Geography Outlook
3.9. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cancer, cardiovascular disorders (CVDs) and metabolic disorder
5.1.1.2. Technology advancement and R & D investment in new peptides
5.1.2. Restraints
5.1.2.1. Poor chemical and physical stability and a short circulating plasma half-life of naturally occurring peptides
5.1.3. Opportunities
5.1.3.1. Presence of strong product pipeline portfolio
5.1.3.2. Adoption of new platforms that develop next-generation protein or peptide therapeutics
5.1.4. Challenges
5.1.4.1. Presence of stringent safety regulations
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY TECHNOLOGY
6.1. Introduction
6.2. Hybrid Phase
6.3. Liquid Phase
6.4. Solid Phase
7. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY API TYPE
7.1. Introduction
7.2. CMO
7.3. In-house
8. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY DRUG CLASS
8.1. Introduction
8.2. Calcitonins
8.3. Glucagon & Analogs
8.4. Insulins
8.5. Luteinizing Hormone-Releasing Hormone
8.6. Somatostatins
8.7. Vasopressin
9. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY APPLICATION
9.1. Introduction
9.2. Anti-infective
9.3. Cancer
9.4. Cardio Vascular Disease Respiratory
9.5. Central Nervous System
9.6. Dermatology
9.7. Gastrointestinal
9.8. Metabolic
9.9. Renal
10. GLOBAL PEPTIDE THERAPEUTICS MARKET, BY END USER
10.1. Introduction
10.2. Hospitals
10.3. Pharmaceutical Industries
10.4. Research Laboratories
11. AMERICAS PEPTIDE THERAPEUTICS MARKET
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand
13. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. COMPETITIVE LANDSCAPE
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. COMPANY USABILITY PROFILES
15.1. AmbioPharm Inc.
15.2. Amgen Inc.
15.3. AstraZeneca PLC
15.4. Bachem Holding AG
15.5. Bristol-Myers Squibb Company
15.6. CordenPharma International
15.7. Eli Lilly and Company
15.8. F. Hoffmann-La Roche AG
15.9. GlaxoSmithKline PLC
15.10. Hemmo Pharmaceuticals Pvt Ltd.
15.11. Ipsen S.A.
15.12. Merck & Co., Inc.
15.13. Novartis International AG
15.14. Novo Nordisk A/S
15.15. Pfizer Inc.
15.16. PolyPeptide Group
15.17. Sanofi S.A.
15.18. Takeda Pharmaceutical Company Limited
15.19. Teva Pharmaceutical Industries Ltd.
15.20. Zealand Pharma A/S
16. APPENDIX
16.1. Discussion Guide
16.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYBRID PHASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID PHASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOLID PHASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CMO, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY IN-HOUSE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CALCITONINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GLUCAGON & ANALOGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INSULINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUTEINIZING HORMONE-RELEASING HORMONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOMATOSTATINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY VASOPRESSIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIO VASCULAR DISEASE RESPIRATORY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DERMATOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RENAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL INDUSTRIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 154. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 156. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 158. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 160. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 162. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 164. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 165. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 166. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 167. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 168. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 169. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 170. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 171. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 172. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 173. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 174. GLOBAL PEPTIDE THERAPEUTICS MARKET: SCORES
TABLE 175. GLOBAL PEPTIDE THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 176. GLOBAL PEPTIDE THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 177. GLOBAL PEPTIDE THERAPEUTICS MARKET: RANKING
TABLE 178. GLOBAL PEPTIDE THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 179. GLOBAL PEPTIDE THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 180. GLOBAL PEPTIDE THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 181. GLOBAL PEPTIDE THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 182. GLOBAL PEPTIDE THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 183. GLOBAL PEPTIDE THERAPEUTICS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYBRID PHASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID PHASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOLID PHASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CMO, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY IN-HOUSE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CALCITONINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GLUCAGON & ANALOGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INSULINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUTEINIZING HORMONE-RELEASING HORMONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOMATOSTATINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY VASOPRESSIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIO VASCULAR DISEASE RESPIRATORY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DERMATOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RENAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL INDUSTRIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. NETHERLANDS PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. QATAR PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. SAUDI ARABIA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 154. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 156. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 158. SOUTH AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 160. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 162. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. SPAIN PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 164. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 165. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 166. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 167. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 168. UNITED ARAB EMIRATES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 169. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 170. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 171. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 172. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 173. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 174. GLOBAL PEPTIDE THERAPEUTICS MARKET: SCORES
TABLE 175. GLOBAL PEPTIDE THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 176. GLOBAL PEPTIDE THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 177. GLOBAL PEPTIDE THERAPEUTICS MARKET: RANKING
TABLE 178. GLOBAL PEPTIDE THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 179. GLOBAL PEPTIDE THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 180. GLOBAL PEPTIDE THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 181. GLOBAL PEPTIDE THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 182. GLOBAL PEPTIDE THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 183. GLOBAL PEPTIDE THERAPEUTICS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL PEPTIDE THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PEPTIDE THERAPEUTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 6. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 7. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 9. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 10. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 11. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 12. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 14. GLOBAL PEPTIDE THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 15. GLOBAL PEPTIDE THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 16. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (%)
FIGURE 17. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025
FIGURE 19. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYBRID PHASE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID PHASE, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOLID PHASE, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2020 VS 2025 (%)
FIGURE 23. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2025
FIGURE 25. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CMO, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY IN-HOUSE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 28. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 30. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CALCITONINS, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GLUCAGON & ANALOGS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INSULINS, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUTEINIZING HORMONE-RELEASING HORMONE, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOMATOSTATINS, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY VASOPRESSIN, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 37. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025
FIGURE 39. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVE, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIO VASCULAR DISEASE RESPIRATORY, 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DERMATOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RENAL, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 48. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025
FIGURE 50. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2020 VS 2025 (USD MILLION)
FIGURE 51. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL INDUSTRIES, 2020 VS 2025 (USD MILLION)
FIGURE 52. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2020 VS 2025 (USD MILLION)
FIGURE 53. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 54. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 56. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 62. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 64. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 76. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. N
FIGURE 1. GLOBAL PEPTIDE THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PEPTIDE THERAPEUTICS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 6. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 7. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 9. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 10. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 11. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 12. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 14. GLOBAL PEPTIDE THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 15. GLOBAL PEPTIDE THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 16. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (%)
FIGURE 17. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TECHNOLOGY, 2025
FIGURE 19. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYBRID PHASE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID PHASE, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOLID PHASE, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2020 VS 2025 (%)
FIGURE 23. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY API TYPE, 2025
FIGURE 25. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CMO, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY IN-HOUSE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 28. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 30. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CALCITONINS, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GLUCAGON & ANALOGS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INSULINS, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUTEINIZING HORMONE-RELEASING HORMONE, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SOMATOSTATINS, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY VASOPRESSIN, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 37. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025
FIGURE 39. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVE, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CANCER, 2020 VS 2025 (USD MILLION)
FIGURE 41. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIO VASCULAR DISEASE RESPIRATORY, 2020 VS 2025 (USD MILLION)
FIGURE 42. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2020 VS 2025 (USD MILLION)
FIGURE 43. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DERMATOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RENAL, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 48. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025
FIGURE 50. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2020 VS 2025 (USD MILLION)
FIGURE 51. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL INDUSTRIES, 2020 VS 2025 (USD MILLION)
FIGURE 52. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2020 VS 2025 (USD MILLION)
FIGURE 53. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 54. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 56. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 62. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 64. AUSTRALIA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. CHINA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. INDIA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. INDONESIA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. JAPAN PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. MALAYSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. PHILIPPINES PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SOUTH KOREA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. THAILAND PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 76. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. ITALY PEPTIDE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. N
